Glenmark appoints Dipankar Bhattacharjee to its board of directors

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has appointed Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization for a period of five years with effect from 14th August, 2020.

Bhattacharjee was previously President & CEO – Global Generic Medicines of Teva Pharmaceutical Industries Ltd and has over thirty years of global pharmaceutical experience.